-
Dec 9, 2014, 09:20 AM
by
Michael Croft
Bio-IT World | Researchers from
Arizona State University and IBM’s TJ Watson Research Center present the
development of a solid state tunneling device sensitive to nucleotides. The
next steps may reveal the direction in which nanopore sequencing is heading.
Full story
-
Dec 9, 2014, 00:00 AM
by
Michael Croft
SAN FRANCISCO, CA - Dec 9, 2014 - The global market for hearing aids is expected to reach USD 5,440.5 million by 2020, growing at an estimated CAGR of 3
Full story
-
Dec 9, 2014, 00:00 AM
by
Michael Croft
SAN FRANCISCO, CA - Dec 9, 2014 - was a professional and depth research report on Global Aluminum Chloride industry that you would know the world's major regional market conditions of Aluminum Chloride industry, the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc
Full story
-
Dec 9, 2014, 00:00 AM
by
Michael Croft
CALIFORNIA, UNITED KINGDOM - Dec 9, 2014 - Industry
InsightsThe ATE market has potential for high growth due
to demand from consumer electronics industry
Full story
-
Dec 9, 2014, 00:00 AM
by
Michael Croft
CALIFORNIA, CA, UNITED STATES - Dec 9, 2014 - Industry
InsightsRising penetration of automated or computerized
surgical technologies such as nanorobots or telemedicine or
bacteriobots for treating fatal diseases such as cancer is expected
to boost market growth in coming six years
Full story
-
Dec 9, 2014, 00:00 AM
by
Michael Croft
SAN FRANCISCO, CA - Dec 9, 2014 - The global market for skincare devices is expected to reach USD 12,799.5 million by 2020, growing at an estimated CAGR of 10
Full story
-
Dec 9, 2014, 00:00 AM
by
Michael Croft
SAN FRANCISCO, CA - Dec 9, 2014 - Global ITP therapeutics market is expected to reach USD 566.37 million by 2020, according to a new study by Grand View Research, Inc
Full story
-
Dec 9, 2014, 00:00 AM
by
Michael Croft
SAN FRANCISCO, CA - Dec 9, 2014 - The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10
Full story
-
Dec 8, 2014, 10:00 AM
by
Michael Croft
Bio-IT World | BaseHealth of Redwood City, Calif., has announced a partnership with the European diagnostics network Labco to deploy BaseHealth’s Genophen platform to thousands of physicians across Europe
Full story
-
Dec 8, 2014, 00:00 AM
by
Michael Croft
BOSTON, MA - Dec 8, 2014 - Terascala, the industry leader in High Performance Computing (HPC) storage management software, today announced that it has released open-source parallel file system Lustre version 2
Full story
-
Dec 8, 2014, 00:00 AM
by
Michael Croft
Boston Herald | Most parents would like to have
their newborns genetically tested for medical conditions and
disorders, according to a new study published this wee
Full story
-
Dec 8, 2014, 00:00 AM
by
Michael Croft
Omics! Omics! Blog | Keith Robison: "It's sobering
to think how few of the targets of current therapeutics could be
found from genomics data."
Full story
-
Dec 5, 2014, 09:55 AM
by
Michael Croft
MIT Technology Review | As Editas Medicine claims exclusive licenses to use key intellectual property around the CRISPR-Cas9 gene editing system, many of the innovators of this technology are disputing patent priority, or even the right to patent foundational CRISPR engineering techniques.
Full story
-
Dec 5, 2014, 00:00 AM
by
Michael Croft
BILLERICA, MA - Dec 5, 2014 - RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the formation of the RainDance HemOnc Consortium, composed of a select group of hematologic clinical research experts drawn from prominent comprehensive cancer centers in the U
Full story
-
Dec 4, 2014, 11:00 AM
by
Michael Croft
Bio-IT World | Eric Alm, co-director of the new Center for Microbiome Informatics and Therapeutics at MIT and MGH, talks microbial therapies, new regulatory models, and the public appeal of our microbes.
Full story
-
Dec 4, 2014, 00:00 AM
by
Michael Croft
PHILADELPHIA, PA, UNITED STATES - Dec 4, 2014 - The Intellectual Property & Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, today announced a collaboration with Linguamatics to advance pharmaceutical clinical trial research and development (R&D) with the launch of CortellisTM Informatics Clinical Text Analytics for I2E
Full story
-
Dec 4, 2014, 00:00 AM
by
Michael Croft
PHILADELPHIA, PA - Dec 4, 2014 - The Intellectual Property & Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, today announced a collaboration with Linguamatics to advance pharmaceutical clinical trial research and development (R&D) with the launch of CortellisTM Informatics Clinical Text Analytics for I2E
Full story
-
Dec 4, 2014, 00:00 AM
by
Michael Croft
PROVO, UT - Dec 4, 2014 - Tute
Genomics, a leader in cloud-based solutions for genome analysis,
has raised $2
Full story
-
Dec 4, 2014, 00:00 AM
by
Michael Croft
Forbes | Former pharmaceutical executive Fred
Eshelman has pledged $100 million to spur innovation at the UNC's
pharmacy school.
Full story
-
Dec 2, 2014, 12:00 PM
by
Michael Croft
Bio-IT World | Editas Medicine, a Cambridge company tackling therapies based on CRISPR gene editing, announced three intellectual property licensing deals with major research institutions this week, gaining exclusive access to key CRISPR-related technologies.
Full story